A detailed history of Acadian Asset Management LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Acadian Asset Management LLC holds 10,430 shares of CDXC stock, worth $75,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,430
Previous 13,265 21.37%
Holding current value
$75,096
Previous $35,000 8.57%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.51 - $3.8 $7,115 - $10,773
-2,835 Reduced 21.37%
10,430 $38,000
Q2 2024

Aug 06, 2024

SELL
$2.44 - $4.32 $15,118 - $26,766
-6,196 Reduced 31.84%
13,265 $35,000
Q1 2024

May 10, 2024

BUY
$1.36 - $3.84 $26,466 - $74,730
19,461 New
19,461 $67,000
Q4 2022

Feb 14, 2023

BUY
$1.25 - $1.94 $19,788 - $30,712
15,831 New
15,831 $26,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $492M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.